Results
|
21.
|
MK-0457, an Aurora kinase and BCR-ABL inhibitor, is active in patients with BCR-ABL T315I leukemia. [electronic resource] by
- Giles, F J
- Swords, R T
- Nagler, A
- Hochhaus, A
- Ottmann, O G
- Rizzieri, D A
- Talpaz, M
- Clark, J
- Watson, P
- Xiao, A
- Zhao, B
- Bergstrom, D
- Le Coutre, P D
- Freedman, S J
- Cortes, J E
Producer: 20130228
In:
Leukemia vol. 27
Availability: No items available.
|
|
22.
|
Differential impact of inhibitory and activating Killer Ig-Like Receptors (KIR) on high-risk patients with myeloid and lymphoid malignancies undergoing reduced intensity transplantation from haploidentical related donors. [electronic resource] by
- Chen, D-F
- Prasad, V K
- Broadwater, G
- Reinsmoen, N L
- DeOliveira, A
- Clark, A
- Sullivan, K M
- Chute, J P
- Horwitz, M E
- Gasparetto, C
- Long, G D
- Yang, Y
- Chao, N J
- Rizzieri, D A
Producer: 20121002
In:
Bone marrow transplantation vol. 47
Availability: No items available.
|
|
23.
|
Apolipoprotein E genotype as a determinant of survival in chronic lymphocytic leukemia. [electronic resource] by
- Weinberg, J B
- Volkheimer, A D
- Mihovilovic, M
- Jiang, N
- Chen, Y
- Bond, K
- Moore, J O
- Gockerman, J P
- Diehl, L F
- de Castro, C M
- Rizzieri, D A
- Levesque, M C
- Dekroon, R
- Strittmatter, W J
Producer: 20090127
In:
Leukemia vol. 22
Availability: No items available.
|
|
24.
|
Prognostic and predictive factors for patients with metastatic breast cancer undergoing aggressive induction therapy followed by high-dose chemotherapy with autologous stem-cell support. [electronic resource] by
- Rizzieri, D A
- Vredenburgh, J J
- Jones, R
- Ross, M
- Shpall, E J
- Hussein, A
- Broadwater, G
- Berry, D
- Petros, W P
- Gilbert, C
- Affronti, M L
- Coniglio, D
- Rubin, P
- Elkordy, M
- Long, G D
- Chao, N J
- Peters, W P
Producer: 20000104
In:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology vol. 17
Availability: No items available.
|
|
25.
|
Pre-engraftment syndrome after myeloablative dual umbilical cord blood transplantation: risk factors and response to treatment. [electronic resource] by
- Kanda, J
- Kaynar, L
- Kanda, Y
- Prasad, V K
- Parikh, S H
- Lan, L
- Shen, T
- Rizzieri, D A
- Long, G D
- Sullivan, K M
- Gasparetto, C
- Chute, J P
- Morris, A
- Winkel, S
- McPherson, J
- Kurtzberg, J
- Chao, N J
- Horwitz, M E
Producer: 20140204
In:
Bone marrow transplantation vol. 48
Availability: No items available.
|
|
26.
|
Prognostic factors for outcomes in allogeneic transplantation for CML in the imatinib era: a CIBMTR analysis. [electronic resource] by
- Khoury, H J
- Kukreja, M
- Goldman, J M
- Wang, T
- Halter, J
- Arora, M
- Gupta, V
- Rizzieri, D A
- George, B
- Keating, A
- Gale, R P
- Marks, D I
- McCarthy, P L
- Woolfrey, A
- Szer, J
- Giralt, S A
- Maziarz, R T
- Cortes, J
- Horowitz, M M
- Lee, S J
Producer: 20121002
In:
Bone marrow transplantation vol. 47
Availability: No items available.
|
|
27.
|
Alternative donors extend transplantation for patients with lymphoma who lack an HLA matched donor. [electronic resource] by
- Bachanova, V
- Burns, L J
- Wang, T
- Carreras, J
- Gale, R P
- Wiernik, P H
- Ballen, K K
- Wirk, B
- Munker, R
- Rizzieri, D A
- Chen, Y-B
- Gibson, J
- Akpek, G
- Costa, L J
- Kamble, R T
- Aljurf, M D
- Hsu, J W
- Cairo, M S
- Schouten, H C
- Bacher, U
- Savani, B N
- Wingard, J R
- Lazarus, H M
- Laport, G G
- Montoto, S
- Maloney, D G
- Smith, S M
- Brunstein, C
- Saber, W
Producer: 20150928
In:
Bone marrow transplantation vol. 50
Availability: No items available.
|